Page last updated: 2024-12-06

altenuene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

altenuene: metabolite of Alternaria; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

altenuene : A benzochromenone mycotoxin isolated from the fungus Allernaria tenuis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID34687
CHEMBL ID482228
MeSH IDM0119362

Synonyms (17)

Synonym
MEGXM0_000136
altenuene
brn 4153870
6h-dibenzo(b,d)pyran-6-one, 2,3,4,4a-tetrahydro-2,3,7-trihydroxy-9-methoxy-4a-methyl-, (2-alpha,3-beta,4a-beta)-(+-)-
NCGC00179755-01
ACON0_001041
ACON1_002175
BRD-K26184114-001-01-8
(2s,3s,4as)-2,3,7-trihydroxy-9-methoxy-4a-methyl-3,4-dihydro-2h-benzo[c]chromen-6-one
CHEMBL482228
29752-43-0
ccris 8303
5-18-05-00113 (beilstein handbook reference)
NCGC00179755-02
DTXSID60891799
(2s,3s,4as)-2,3,7-trihydroxy-9-methoxy-4a-methyl-4,4a-dihydro-2h-benzo[c]chromen-6(3h)-one
Q63409701

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID467453Antibacterial activity against multidrug-resistant Acinetobacter baumannii by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467455Antifungal activity against multidrug-resistant Aspergillus fumigatus by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467452Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467445Antibacterial activity against multidrug-resistant Streptococcus pneumoniae by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID376262Antibacterial activity against Staphylococcus aureus ATCC 29213 at 100 ug/disk by disk diffusion method2006Journal of natural products, Apr, Volume: 69, Issue:4
Altenuene derivatives from an unidentified freshwater fungus in the family Tubeufiaceae.
AID467444Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467447Antibacterial activity against multidrug-resistant Enterobacter cloacae by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467448Antifungal activity against multidrug-resistant Aspergillus ficuum by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467450Antibacterial activity against multidrug-resistant Escherichia coli by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467449Antifungal activity against multidrug-resistant Candida albicans by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467454Antifungal activity against multidrug-resistant Candida krusei by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID376263Antibacterial activity against Bacillus subtilis ATCC 6051 at 100 ug/disk by disk diffusion method2006Journal of natural products, Apr, Volume: 69, Issue:4
Altenuene derivatives from an unidentified freshwater fungus in the family Tubeufiaceae.
AID467446Antibacterial activity against multidrug-resistant Enterococcus faecium by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
AID467451Antibacterial activity against multidrug-resistant Klebsiella pneumoniae by broth dilution method2009Journal of natural products, Nov, Volume: 72, Issue:11
Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.25)18.7374
1990's5 (15.63)18.2507
2000's7 (21.88)29.6817
2010's13 (40.63)24.3611
2020's5 (15.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.08 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]